Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A clinical study of MK-1403 in healthy men (MK-1403-004) Ended

2024-514629-52-00 Atherosclerosis 3 2024-10-28
A clinical study of MK-3214 in healthy people (MK-3214-001) Ended

2024-516016-17-00 Hypercholesterolaemia 1 2024-10-22
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With… Ended

2024-513143-82-00 Heart failure with reduced ejection fraction 3 2024-10-15
A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142 Ended

2024-510765-42-00 Chronic kidney disease 3 2024-10-01
A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin. Ended

2024-514431-18-00 Heart Failure 1 2024-10-01
Phase Ib Randomised, Placebo-controlled, Double-blind, Multicentre Study to Assess the Effects and Safety of AZD5462 on top of Dapagliflozin… Ended

2024-513142-11-00 Moderate Renal Impairment 3 2024-09-27
Peripheral Edema Resolution evaluated in patients switched from amlodipine to Levamlodipine (PERLA) Ended

2024-511312-24-00 Patients with moderate or severe oedema on a long-term 4 2024-09-25
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally In… Ended

2023-508603-21-00 Venous Thromboembolism 4 2024-09-20
Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study Ended

2024-517354-98-00 CMV infection in heart transplant recipients 4 2024-09-17
A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodi… Ended

2024-514456-32-00 hypertension 2 2024-09-09
A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Repeated Subcuta… Ended

2023-510370-14-00 Stable Coronary Artery Disease 4 2024-08-28
MK-0616 versus Comparators Study in Adults with Hypercholesterolemia Ended

2023-504920-25-00 Hypercholesterolemia 5 2024-08-23
A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing apixaban 5 mg hard capsules (PG412 [Celon Pharma]) vs … Ended

2024-511526-31-00 Prevention of stroke and systemic embolism in adult pat 2 2024-08-20
A study to learn about how well a new drug called BAY3283142 works and how safe it is in reducing albumin in the urine of people with chroni… Ended

2023-505755-40-00 Chronic kidney disease 4 2024-08-16
Randomised, bioequivalence clinical trial of atorvastatin 80 mg capsules vs atorvastatin 80 mg film-coated tablets, after a single oral dose… Ended

2024-512596-12-00 Hypercholesterolaemia 2 2024-08-16
A pivotal, randomized, open-label, two-treatment, two-sequence, four periods, crossover clinical trial to evaluate the bioequivalence of sin… Ended

2023-509484-24-00 Healthy 2 2024-08-10
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejec… Ended

2023-508736-62-00 Heart failure (HF) with reduced ejection fraction (HFrE 4 2024-08-08
A Phase 2 Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejecti… Ended

2023-508737-13-00 chronic heart failure 4 2024-08-08
Co-administration of Acetaminophen with Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants – The ACEDUCT Trial Ended

2023-503209-13-00 Patent ductus arteriosus (PDA) 4 2024-08-07
A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure Ended

2024-512060-58-00 Chronic kidney disease 3 2024-08-07
A clinical study of MK-2828 in healthy people (MK-2828-001) Ended

2024-513377-51-00 Atherosclerosis 1 2024-08-01
A study to learn about the amount of asundexian in the blood when healthy participants take different types of asundexian tablets Ended

2023-509447-28-00 Prevention of ischemic stroke in patients post acute no 3 2024-07-26
Cardiodoron® vs. placebo for functional cardiovascular disorders (FCD) Ended

2024-511210-21-00 functional cardiovascular disorders 6 2024-07-23
An open label, randomized, single-dose, two-sequence, two-period, crossover comparative bioavailability study to assess the pharmacokinetic … Ended

2023-510176-31-00 This study is a phase I trial, a single-dose, open labe 3 2024-07-22